Main useUsed for selected cancers, including melanoma, lung and kidney cancer, under disease-specific conditions.A brief overview of Japanese approved uses. Check the PMDA label below for product-specific conditions.
- Japan product name
- オプジーボ点滴静注20mg／100mg／120mg／240mg
- Brand
- Opdivo
- Generic name
- Nivolumab
- Japanese generic name
- ニボルマブ
- Chinese name
- 纳武利尤单抗
- Marketing authorization holder
- 小野薬品工業株式会社
- Strengths
- 20 mg / 100 mg / 120 mg / 240 mg
- Dosage form
- IV infusion
- Therapeutic area
- Oncology
- Regulatory status
- Rx
- Label updated
- 2026-08-25
- TOKYO MEDI verified
- 2026-09-22
Official source
These links go directly to PMDA records for this Japanese product. Professional and patient-facing sources are separated.